Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial.
15
0
0
Texte intégral
Figure
Documents relatifs
Prognostic fac- tors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo- adjuvant chemotherapy followed by interval debulking surgery: